Advertisement

Topics

Acting Commissioner Ned Sharpless Affirms Commitment to FDA’s Current Course

20:00 EDT 16 Apr 2019 | BioSpace

As Ned Sharpless takes over as acting commissioner of the U.S. Food and Drug Administration, he is not planning any disruptions or course corrections to the federal regulatory agency.

Original Article: Acting Commissioner Ned Sharpless Affirms Commitment to FDA’s Current Course

NEXT ARTICLE

More From BioPortfolio on "Acting Commissioner Ned Sharpless Affirms Commitment to FDA’s Current Course"

Advertisement
Quick Search
Advertisement
Advertisement